Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04121806

Diet Intervention Treatment for Active Ulcerative Colitis

Diet Intervention as a Prebiotic Treatment for Active Ulcerative Colitis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Mount Sinai Hospital, Canada · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if a sustainable non-elemental diet can be used as a probiotic tool to alter the dysbiotic microbiome found in individuals with ulcerative colitis and thereby decrease disease activity.

Detailed description

The etiology of inflammatory bowel disease (IBD), including ulcerative colitis (UC), is complex and poorly understood, but the current hypothesis is that IBD arises from an aberrant immune response to commensal bacteria in a genetically susceptible host, and is triggered by environmental factors. Environmental factors such as the microbiome and diet, play a significant role in the risk of IBD. Diet has been identified as one of the main drivers of the microbiome composition and the microbiome and diet can work in tandem to affect host physiology. In spite of patient interest in diet and numerous diet studies, currently there is no diet that is clinically validated or universally agreed upon for adult IBD patients. We also lack rigorous studies to show how the microbiome is influenced by diet and affects patient outcomes. We propose to use a sustainable non-elemental diet aimed at altering the microbiome in patients with mild to moderately active UC to alter their disease activity.

Conditions

Interventions

TypeNameDescription
OTHERUC intervention dietThe treatment diet has been designed based on the literature with the goal of influencing the biodiversity and density of the microbiome. All food through the duration of the 8 week dietary intervention period of the study will be provided to the treatment arm study participants.

Timeline

Start date
2021-03-01
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2019-10-10
Last updated
2025-09-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04121806. Inclusion in this directory is not an endorsement.